National Asian Language Tobacco Use and Dependence Treatment Support System
Quitlines are one of the most accessible tobacco use and dependence treatment resources that can efficiently reach people who use tobacco. Telephone quitlines increase quit rates among individuals who use tobacco and are trying to quit, and are effective in reaching and supporting diverse and low-income populations. There are currently 12 quitline providers operating state quitlines in every state, the District of Columbia, Guam, and Puerto Rico. Advances in new digital-based quit support services (e.g., texting, chat, web, apps) show great promise in expanding the reach of the quitline to create state-based tobacco use and dependence treatment systems. Limited capacity to provide linguistically and culturally appropriate services may create barriers that contribute to tobacco-related disparities, especially among various subgroups of Asian Americans that speak Chinese (including Cantonese and Mandarin), Korean, and Vietnamese languages (CKV). Most state quitlines do not have staff with the needed language skills to provide in-language services to callers who speak CKV languages. Since October 2012, the Asian Smokers’ Quitline (ASQ) has been serving CKV-speaking populations nationally and has enrolled over 15,000 callers from all 50 states and the District of Columbia. CDC will provide continued support for a national Asian language quitline to complement the national portals 1-800-QUIT-NOW (transfers English-speaking callers to English-language services available through their state quitlines) and 1-855-DEJELO-YA (transfers Spanish-speaking callers to Spanish-language services available through their state quitlines). This Notice of Funding Opportunity (NOFO) supports one recipient to operate and promote a linguistically and culturally appropriate nationwide quitline service for individuals who use tobacco and who predominantly speak CKV languages.
Funding Agency: Centers for Disease Control – NCCDPHP
Deadline: January 7, 2020
Amount: $700,000
For more information: Go to grants.gov and search opportunity # CDC-RFA-DP20-2006
Air Superiority Technology Broad Agency Announcement
Funding Agency: Munitions Directorate
Deadline: October 31, 2024
For more information: Go to grants.gov and search opportunity #FA8651-20-S-0008
Notice of Intent to Publish a Funding Opportunity Announcement for Implementing the HIV Service Cascade for Justice-Involved Populations
NIDA intends to publish a funding opportunity announcement for cooperative agreements that will examine the delivery of the full continuum of HIV services for adults with injection drug use or opioid use disorder in US community corrections populations (probation/parole). This Notice is being provided to allow the potential investigators sufficient time to develop meaningful collaborations, identify appropriate communities, and create responsive applications. The FOA is expected to use the cooperative clinical trial mechanism (U01). The FOA is expected to be published in February 2020 with expected application due dates in April 2020. As a cooperative, it is expected that investigators upon funding will work jointly with federal staff at NIH/NIDA and with other funded grantees to achieve study goals. Details of the planned FOA are provided below.
Funding Agency: National Institute of Health
Deadline: April 1, 2020
Amount: $2,000,000
For more information: Go to grants.gov and search opportunity # NOT-DA-20-003
Notice of Intent to Publish the Reissuance of a Funding Opportunity Announcement for Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Centers Without Walls (U54)
This Notice is to inform the research community that The National Institute of Neurological Disorders and Stroke (NINDS) intends to reissue the Funding Opportunity Announcement (FOA) RFA-NS-19-022 “Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW).” When reissued, this FOA will continue to utilize the U54 grant mechanism. The research priorities will remain the same but will include some points of clarification. Modifications to this FOA will include the addition of research cores and a reduction in the number of required research projects from three projects to a single research project. Like the initial FOA, the reissued FOA will solicit applications for research on discovering and performing an initial clinical validation of biological measures to be used for prognosing and monitoring recovery of adolescents who either clinically present with or are at risk for developing prolonged/persistent concussive symptoms following exposure to concussion and/or repetitive head impacts. These biological measures should then be incorporated into risk stratification algorithms to inform clinical care and patient stratification for future clinical trials. A key component of this FOA will be the broad sharing of clinical, neuroimaging, physiological, and biospecimen data to further advance research in the area of persistent concussive symptoms in early and middle adolescent (EMA; ages 11-17 years old) populations. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and an appropriate project design. The FOA is expected to be published in Winter 2019 with an expected application due date in Spring 2020. This FOA will utilize the NIH Specialized Center Cooperative Agreement (U54) activity code. Details of the planned FOA are provided below.
Funding Agency: National Institutions of Health
Deadline: March 23, 2020
Amount: $2,000,000
For more information: Go to grants.gov and search opportunity # NOT-NS-20-014
Notice of Intent to Publish the Reissuance of PAR-18-644 and PAR-18-645 for Research Infrastructure Development for Interdisciplinary Aging Studies (R33 and R21/R33)
This Notice informs the research community that the National Institute on Aging (NIA) intends to reissue Funding Opportunity Announcements (FOAs) PAR-18-644 “Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 – Clinical Trial Optional)” and PAR-18-645 “Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 – Clinical Trial Optional).” When reissued, the FOAs will continue to use the R33 and R21/R33 grant mechanisms, respectively, to support network and infrastructure development activities. Scientific scope of the reissued FOAs will be broadened to encompass the interests of all four NIA extramural funding divisions. This Notice is being provided to inform potential applicants of the availability of continued opportunities to submit applications beyond expiration of the currently active FOAs. The FOA is expected to be published in December 2019 with an expected initial application due date of February 16, 2020.
Funding Agency: National Institute of Health
Deadline: February 16, 2020
Amount: $499,999
For more information: Go to grants.gov and search opportunity # NOT-AG-20-004
Notice of Intent to Publish a Funding Opportunity Announcement for Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 – Independent Clinical Trial Not Allowed)
This Notice is to inform the research community of the reissuance of RFA-OD-18-007, “Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 – Independent Clinical Trial Not Allowed.” When reissued, this FOA will continue to use the K99/R00 activity code. Modifications to this FOA will be the inclusion of new and revised research priorities. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in Spring 2020 with an expected application due date in Summer 2020.
Funding Agency: National Institute of Health
Deadline: July 7, 2020
For more information: Go to grants.gov and search opportunity # NOT-OD-20-006
Notice of Intent to Publish a Funding Opportunity Announcement for Pilot Effectiveness Trials for Rapid-Acting Interventions for Severe Suicide Risk (R01 Clinical Trial Required)
The NIMH intends to promote a new initiative through a Funding Opportunity Announcement (FOA) that will solicit applications to test the feasibility of rapid-acting interventions to reduce suicide risk through clinical trials that are based in appropriate/specialized healthcare settings (e.g., emergency departments, psychiatric inpatient units, settings that meet Risk Evaluation and Mitigation Strategy approaches). This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in December 2019 with an expected application due date in February 2020. This FOA will utilize the R01 activity code. Details of the planned FOA are provided below.
Funding Agency: National Institute of Health
Deadline: February 25, 2020
For more information: Go to grants.gov and search opportunity # NOT-MH-19-044
Notice of Intent to Publish a Funding Opportunity Announcement for Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 – Independent Clinical Trial Required)
This Notice is to inform the research community of the reissuance of RFA-OD-18-006, “Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 Clinical Trial Required).” When reissued, this FOA will continue to utilize the K01 grant mechanism. Modifications to this FOA will be the inclusion of new and revised research priorities. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and appropriate projects. The FOA is expected to be published in Spring 2020 with an expected application due date in Summer 2020.
Funding Agency: National Institutes of Health
Deadline: July 7, 2020
For more information: Go to grants.gov and search opportunity # NOT-OD-20-007
Notice of Intent to Publish a Funding Opportunity Announcement for a Coordinating Center for Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry (U01 Clinical Trial Not Allowed)
The National Human Genome Research Institute intends to issue a Funding Opportunity Announcement (FOA) to solicit applications to support a Coordinating Center for Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry. The intended FOA will be based on a concept recently approved by the National Advisory Council on Human Genome Research and accompanying discussion (https://www.genome.gov/sites/default/files/media/files/2019-09/Sept2019_Council_Hindorff_PolygenicRiskScore_RFA_Concept.pdf and https://www.youtube.com/watch?v=x0-hw7DoOQU). This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in January, 2020 with an expected application due date in Summer, 2020. This FOA will utilize the U01 activity code. Details of the planned FOA are provided below.
Funding Agency: National Institute of Health
Deadline: June 2, 2020
Amount: $1,600,000
For more information: Go to grants.gov and search opportunity # NOT-HG-20-006
Notice of Intent to Publish a Funding Opportunity Announcement for Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (R35- Clinical Trial Optional)
The purpose of this Notice is to inform the biomedical research community that NIGMS is planning to issue a funding opportunity announcement (FOA) to continue the Maximizing Investigators’ Research Award for Early Stage Investigators (MIRA-ESI) (R35) program. The FOA is intended for new applications from early stage investigators. This Notice is being provided to allow potential applicants sufficient time to develop responsive projects. The FOA is expected to be published in Spring 2020 with an expected first application due date in October 2020. This FOA will utilize the R35 activity code. Details of the planned FOA are provided below.
Funding Agency: National Institute of Health
Deadline: October 5, 2020
Amount: $250,000
For more information: Go to grants.gov and search opportunity # NOT-GM-19-061
Notice of Intent to Publish a Funding Opportunity Announcement for Centers for Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry (U01 Clinical Trial Not Allowed)
The National Human Genome Research Institute intends to issue a Funding Opportunity Announcement (FOA) to solicit applications to support Centers for Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry. The intended FOA will be based on a concept recently approved by the National Advisory Council on Human Genome Research and accompanying discussion (https://www.genome.gov/sites/default/files/media/files/2019-09/Sept2019_Council_Hindorff_PolygenicRiskScore_RFA_Concept.pdf and https://www.youtube.com/watch?v=x0-hw7DoOQU). This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in January, 2020 with an expected application due date in Summer, 2020. This FOA will utilize the U01 activity code. Details of the planned FOA are provided below.
Funding Agency: National Institutes of Health
Deadline: June 2, 2020
Amount: $1,000,000
For more information: Go to grants.gov and search opportunity # NOT-HG-20-005
Notice of Intent to Publish a Funding Opportunity Announcement for Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 – Independent Clinical Trial Not Allowed)
This Notice is to inform the research community of the reissuance of RFA-OD-18-005, “Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 Clinical Trial Not Allowed).” When reissued, this FOA will continue to utilize the K01 grant mechanism. Modifications to this FOA will be the inclusion of new and revised research priorities. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and appropriate projects. The FOA is expected to be published in Spring 2020 with an expected application due date in Summer 2020.
Funding Agency: National Institute of Health
Deadline: July 7, 2020
Amount: $90,000
For more information: Go to grants.gov and search opportunity # NOT-OD-20-008
Notice of Intent to Publish a Funding Opportunity Announcement for Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 – Independent Clinical Trial Required)
This Notice is to inform the research community of the reissuance of RFA-OD-18-008, “Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 – Independent Clinical Trial Required.” When reissued, this FOA will continue to use the K99/R00 activity code. Modifications to this FOA will be the inclusion of new and revised research priorities. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in Spring 2020 with an expected application due date in Summer 2020.
Funding Agency: National Institutes of Health
Deadline: July 7, 2020
For more information: Go to grants.gov and search opportunity # NOT-OD-20-005
OVW FY 2020 Sexual Assault Forensic-Medical and Advocacy Services for Tribes (FAST) Initiative
The Sexual Assault Forensic-Medical and Advocacy Services for Tribes (FAST) Initiative is a special initiative designed to increase the availability of trained Sexual Assault Forensic Examiners (SAFEs) and trained sexual assault victim advocates in tribal communities, including Alaska Native villages. Funding may be used to establish, sustain, and/or expand programs offering sexual assault medical forensic exams and sexual assault victim services in tribal communities. Furthermore, funding may be used to establish, sustain, and/or expand Sexual Assault Response Teams (SARTs). Funding priority will be given to applicants proposing innovative ways of bringing experienced SAFEs to remote tribal communities, such as traveling SAFEs, telemedicine, and rural preceptorships.
Funding Agency: Office of Violence Against Women
Deadline: January 10, 2020
Amount: $2,000,000
For more information: https://www.justice.gov/ovw/page/file/1214991/download
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-designated Cancer Centers. CCSGs support two types of cancer centers: 1) Comprehensive Cancer Centers, which demonstrate reasonable depth and breadth of research activities in each of three major areas: basic laboratory; clinical; and prevention, control and population-based research, and which have substantial transdisciplinary research that bridges these scientific areas; and 2) Cancer Centers, which are primarily focused on basic laboratory; clinical; and prevention, cancer control, and population-based research; or some combination of these areas. The purpose of both types of NCI-designated Cancer Centers is to capitalize on all institutional cancer research capabilities, integrating meritorious programs in laboratory, clinical, and population research into a single transdisciplinary research enterprise across all institutional boundaries. Cancer Centers supported through this FOA are expected to serve as major sources of discovery of the nature of cancer and of development of more effective approaches to prevention, diagnosis, and therapy; to contribute significantly to the development of shared resources that support research; to collaborate and coordinate their research efforts with other NCI-funded programs and investigators; and to disseminate research findings for the benefit of the community.
Funding Agency: National Institutes of Health
Deadline: September 25, 2021
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-043.html
Building Population Health Research Capacity in the U.S. Affiliated Pacific Islands (U24 Clinical Trial Not Allowed)
The purpose of this initiative is to build the capacity of organizations in the US-Affiliated Pacific Islands to conduct ongoing population health research in this region.
Funding Agency: National Institutes of Health
Deadline: July 15, 20222
Amount: $400,000
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-048.html
Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) encourages applications from integrative teams and individual investigators for large-scale complex multi-disciplinary Functional Genomics Projects (FGPs) to determine the contributions and mechanisms underlying the contribution of associated variants for type 1 diabetes (T1D). Genome-wide association studies (GWAS) and other genomic studies of T1D have found many variants that are statistically associated with disease risk or disease protection, but they have not clearly shown which variants in genomic elements cause these effects or how they result in differences in function. Applications submitted to this RFA will systematically identify causal variants and effector transcripts associated with all known T1D risk variants, verify the role of downstream effector transcripts, build network models that explain their role(s) in T1D. These biological insights could lead to the development of reliable biomarkers and effective strategies for screening and disease prevention, rational drug design, and better tailored therapies.
Funding Agency: National Institutes of Health
Deadline: March 26, 2020
Amount: $850,000
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-020.html
Public Humanities Project
The National Endowment for the Humanities Division of Public Programs is currently accepting proposals for the Public Humanities Projects program. The Public Humanities Projects program supports projects that bring the ideas and insights of the humanities to life for general audiences through in-person programming. Projects must engage humanities scholarship to analyze significant themes in disciplines such as history, literature, ethics, and art history.
Funding Agency: National Endowment for the Humanities
Deadline: January 8, 2020
Amount: $1,000,000
For more information: https://www.neh.gov/grants/public/public-humanities-projects
Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional)
This Funding Opportunity Announcement encourages applications using community-engaged research methods to investigate the potential health risks of environmental exposures of concern to the community and to implement an environmental public health action plan based on research findings. The overall goal is to inform changes and to support efforts to prevent or reduce exposure to harmful environmental exposures and improve the health of a community.
Funding Agency: National Institutes of Health
Deadline: December 4, 2020
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-20-002.html
Assessing the Effects of Cannabinoids on HIV-Induced Inflammation (R01 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement [FOA] is to encourage basic science and preclinical research to determine the biological mechanisms underlying the effects of cannabinoids and the endocannabinoid system on HIV-associated persistent inflammation and its consequent effects on nervous system function. Projects submitted in response to this FOA must include expertise and resources in both areas of HIV/AIDS and addiction science.
Funding Agency: National Institutes of Health
Deadline: March 11, 2020
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-022.html
NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required)
The purpose of the NINDS Postdoctoral Mentored Career Development Award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program. Candidates are encouraged to apply for support from this NINDS K01 any time between the second through fourth year of cumulative mentored postdoctoral research experience, and may be supported by this NINDS K01 within the first 6 years of cumulative postdoctoral research experience. Because the completion of a strong, well-planned, thorough career development plan, in addition to development of an impactful research project, is a critical aspect of this K01, applications are strongly encouraged early in the postdoctoral eligibility window. By the end of the proposed K01 award period, the candidate should be poised to begin an independent research career with a well-developed, impactful research project and the expertise required to become a leader in the field. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development.
Funding Agency: National Institutes of Health
Deadline: January 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-050.html
NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed)
The purpose of the NINDS Postdoctoral Mentored Career Development Award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program. Candidates are encouraged to apply for support from this NINDS K01 any time between the second through fourth year of cumulative mentored postdoctoral research experience, and may be supported by this NINDS K01 within the first 6 years of cumulative postdoctoral research experience. Because the completion of a strong, well-planned, thorough career development plan, in addition to development of an impactful research project, is a critical aspect of this K01, applications are strongly encouraged early in the postdoctoral eligibility window. By the end of the proposed K01 award period, the candidate should be poised to begin an independent research career with a well-developed, impactful research project and the expertise required to become a leader in the field. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.
Funding Agency: National Institutes of Health
Deadline: January 7, 2023
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-049.html
U.S. Embassy Grants Program
The U.S. Embassy in Ankara announces its country-wide Grants Program. Funding is available to support projects that address one or more of the following key bilateral themes:
– Support Shared Security: Projects for consideration in this category could/should support and advance cooperation between the United States and Turkey in bilateral counter terrorism efforts and transnational crime as well as in NATO and other multilateral security organizations.
– Strengthen Economic Prosperity – Promoting Innovation and Fostering Entrepreneurship: Depending on the level of entrepreneurial opportunity and ability in the targeted region(s) for the activity, proposals here could include trainings to introduce the concept and principles of entrepreneurship, promote networking and mentorship opportunities, provide small-and-medium enterprise (SME) development planning, teach marketing and outreach techniques, foster research and development/innovation, etc.
– Reinforce Democratic Values – Media: Proposals should support journalists and/or citizen journalists through trainings or activities to bolster media literacy, investigative journalism, social media/internet publishing, research and fact checking, documentary filmmaking, visual or other storytelling.
– Reinforce Democratic Values – Freedom of Expression and Public Discourse: Proposals should focus on activities to encourage cultural and arts projects promoting public discourse and freedom of opinion, such as through innovative forms of creative expression, reaching and teaching underserved audiences (e.g., ethnic or religious minorities, LGBT, youth or women – or promoting awareness of their issues), encouraging respect of cultural and social diversity, pluralism and equity in cultural life and policy.
– Foster Turkish and U.S. Ties: Proposals for programs developing American Studies, English language teaching/learning, STE(A)M education among Turkish youth and which encourage study in the United States will be considered under this category.
Funding Agency: Bureau of European and Eurasian Affairs
Deadline: January 21, 2020
Amount: $80,000
For more information: https://tr.usembassy.gov/education-culture/grant-opportunities/